Related Experiment Video
Updated: Jul 20, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Translational approaches using metastasis suppressor genes
Diane Palmieri1, Christine E Horak, Jong-Heun Lee
1Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Building 37, Room 1122, NIH, Bethesda, MD 20892, USA.
Abstract:
Cancer metastasis is a significant contributor to breast cancer patient morbidity and mortality. In order to develop new anti-metastatic therapies, we need to understand the biological and biochemical mechanisms of metastasis. Toward these efforts, we and others have studied metastasis suppressor genes, which halt metastasis in vivo without affecting primary tumor growth. The first metastasis suppressor gene identified was nm23, also known as NDP kinase. Nm23 represents the most widely validated metastasis suppressor gene, based on transfection and knock-out mouse strategies. The biochemical mechanism of metastasis suppression via Nm23 is unknown and likely complex. Two potential mechanisms include binding proteins and a histidine kinase activity. Elevation of Nm23 expression in micrometastatic tumor cells may constitute a translational strategy for the limitation of metastatic colonization in high risk cancer patients. To date, medroxyprogesterone acetate (MPA) has been identified as a candidate compound for clinical testing.
Insights
Understanding metastasis suppressor genes like nm23 (NDP kinase) is crucial for developing new anti-metastatic therapies. Research explores nm23
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer metastasis significantly increases patient mortality.
- Metastasis suppressor genes inhibit metastasis without impacting primary tumor growth.
- Nm23 (NDP kinase) is the first and most validated metastasis suppressor gene.
Purpose of the Study:
- To elucidate the biological and biochemical mechanisms of Nm23-mediated metastasis suppression.
- To explore potential therapeutic strategies targeting metastasis.
Main Methods:
- Utilized transfection and knock-out mouse models to study nm23 function.
- Investigated potential biochemical mechanisms including protein binding and histidine kinase activity.
Main Results:
- Nm23 is a validated suppressor of cancer metastasis.
- The precise biochemical mechanism of Nm23 remains under investigation.
- Potential mechanisms involve protein interactions and enzymatic activity.
Conclusions:
- Understanding Nm23 is key to developing anti-metastatic therapies.
- Elevating Nm23 expression may limit metastatic colonization in high-risk patients.
- Medroxyprogesterone acetate (MPA) is a potential therapeutic candidate.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
07:03Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
Published on: February 3, 2021
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...